Report on reimbursement dynamics makes case for price transparency data

The Drug Reimbursement Trends Report—a white paper put together by Turquoise Health and ZS Associates—has found that differential reimbursement dynamics are more pronounced for products that are clinically similar.

It is further identified in the paper, which focuses on the US market, that reimbursement distributions are generally similar across therapy areas, though there is evidence that clinically similar products, such as biosimilars, are more likely to have variability in reimbursement premiums across products.